Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Rambus management to meet with Roth Capital » 04:55
02/21/20
02/21
04:55
02/21/20
04:55
RMBS

Rambus

$16.07 /

-0.27 (-1.65%)

Meeting to be held in San…

Meeting to be held in San Francisco on February 21 hosted by Roth Capital.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Rambus management to meet with Roth Capital » 11:18
02/18/20
02/18
11:18
02/18/20
11:18
RMBS

Rambus

$16.22 /

+ (+0.00%)

Meeting to be held in San…

Meeting to be held in San Francisco on February 21 hosted by Roth Capital.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Rambus price target raised to $17.30 from $16 at Citi » 06:30
01/29/20
01/29
06:30
01/29/20
06:30
RMBS

Rambus

$15.04 /

+0.47 (+3.23%)

Citi analyst Atif Malik…

Citi analyst Atif Malik raised his price target for Rambus to $17.30 from $16 and keeps a Buy rating on the shares following the company's December quarter results. The analyst likes management's renewed focus on "core semiconductor strengths," and highlights its "strong" patent portfolio of interface and security intellectual property.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
Hot Stocks
Fly Intel: After Hours Movers » 18:57
01/27/20
01/27
18:57
01/27/20
18:57
GGG

Graco

$51.41 /

-0.605 (-1.16%)

, BRO

Brown & Brown

$41.70 /

-0.145 (-0.35%)

, IPAR

Inter Parfums

$70.67 /

-1.33 (-1.85%)

, XLRN

Acceleron

$52.83 /

+0.81 (+1.56%)

, SURF

Surface Oncology

$2.93 /

-0.13 (-4.25%)

, MNOV

MediciNova

$6.10 /

-0.26 (-4.09%)

, LAUR

Laureate Education

$17.70 /

+0.04 (+0.23%)

, FFIV

F5 Networks

$132.71 /

-3.14 (-2.31%)

, RMBS

Rambus

$14.57 /

-0.38 (-2.54%)

, JNPR

Juniper

$24.46 /

-0.12 (-0.49%)

, PKI

PerkinElmer

$98.74 /

-1.075 (-1.08%)

, JJSF

J & J Snack Foods

$184.54 /

-2.31 (-1.24%)

, ALEC

Alector

$25.72 /

+1.17 (+4.77%)

, DNLI

Denali Therapeutics

$27.97 /

+3.29 (+13.33%)

UP AFTER EARNINGS: Graco…

UP AFTER EARNINGS: Graco (GGG) up 4.6%... Brown&Brown (BRO) up 2.0%... Inter Parfums (IPAR) up 1.0%. ALSO HIGHER: Acceleron Pharma (XLRN) up 66.1% after announcing its sotatercept trial met endpoints... Surface Oncology (SURF) up 13.8% after getting FDA clearance for SRF617, SRF388 INDs... MediciNova (MNOV) up 11.3% after getting notice of intention to grant patent for MN-001 in Europe... Laureate Education (LAUR) up 4.5% after announcing plans to explore strategic alternatives. DOWN AFTER EARNINGS: F5 Networks (FFIV) down 4.5%... Rambus (RMBS) down 3.2%... Juniper (JNPR) down 2.9%... PerkinElmer (PKI) down 2.7%... J&J Snack Foods (JJSF) down 2.0%. ALSO LOWER: Alector (ALEC) down 2.8% after equity offering... Denali Therapeutics (DNLI) down 2.7% after equity offering. Movers as of 18:45ET.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29
    Jan
  • 30
    Jan
Earnings
Rambus sees Q1 license billings revenue $60M-$66M » 16:10
01/27/20
01/27
16:10
01/27/20
16:10
RMBS

Rambus

$14.63 /

-0.32 (-2.14%)

For the Q1the Company…

For the Q1the Company expects licensing billings to be between $60M-$66M. The Company also expects royalty revenue to be between $7M-$13M, product revenue to be between $18M-$24M and contract and other revenue to be between $13M-$19M. Revenue is not without risk and achieving revenue in this range will require that the Company sign customer agreements for various product sales and solutions licensing, among other matters. The Company also expects operating costs and expenses to be between $80M-$76M. Additionally, the Company expects non-GAAP operating costs and expenses to be between $68M-$64M. These expectations also assume non-GAAP interest and other income (expense), net, of $1M tax rate of 24% and diluted share count of 115M, and exclude stock-based compensation expense ($7M) amortization expense ($5M) non-cash interest expense on convertible notes ($2M) and interest income related to the significant financing component from fixed-fee patent and technology licensing arrangements ($5M).

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Rambus reports Q4 EPS (9c), consensus 25c » 16:07
01/27/20
01/27
16:07
01/27/20
16:07
RMBS

Rambus

$14.66 /

-0.29 (-1.94%)

Reports Q4 revenue…

Reports Q4 revenue $59.9M, consensus $98.02M. "Rambus had an excellent fourth quarter, concluding a very strong year that was propelled by robust cash from operations and record Q4 and annual revenue from memory interface chips and silicon IP," said the company. "By realigning the Company around our core strengths in semiconductor and augmenting our product portfolio, we are well-positioned for continued success in 2020."

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Rambus options imply 7.1% move in share price post-earnings » 15:19
01/27/20
01/27
15:19
01/27/20
15:19
RMBS

Rambus

$14.71 /

-0.24 (-1.61%)

Pre-earnings options…

Pre-earnings options volume in Rambus is 1.2x normal with calls leading puts 5:3. Implied volatility suggests the market is anticipating a move near 7.1%, or $1.04, after results are released. Median move over the past eight quarters is 3.7%.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Unusual call flow in option market yesterday » 07:35
01/10/20
01/10
07:35
01/10/20
07:35
AAPL

Apple

$309.70 /

+6.61 (+2.18%)

, TSLA

Tesla

$481.42 /

-10.53 (-2.14%)

, BYND

Beyond Meat

$90.25 /

+8.79 (+10.79%)

, RMBS

Rambus

$14.18 /

+0.4 (+2.90%)

Notable call activity was…

Notable call activity was cited Thursday in Apple (AAPL), Tesla (TSLA), Beyond Meat (BYND), and Rambus (RMBS).

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Size call buyer in Rambus » 10:10
01/09/20
01/09
10:10
01/09/20
10:10
RMBS

Rambus

$14.28 /

+0.5 (+3.63%)

Size call buyer in…

Size call buyer in Rambus. Shares up 46c, 3%, to $14.26 with 5K calls trading and nearly all the flow in the Feb 15 calls, bought in a number of sweep from 25 to 31c just after 9:48 ET when shares were near $14. Opens and is expected to capture earnings at end of Jan.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Rambus management to meet with Roth Capital » 04:55
12/17/19
12/17
04:55
12/17/19
04:55
RMBS

Rambus

$13.41 /

+0.325 (+2.48%)

Meeting to be held in Los…

Meeting to be held in Los Angeles, CA on December 17 hosted by Roth Capital.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.